TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3714757

Group type: EXPERIMENTAL
Intervention: 100 mg tiropramide
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 150 mg trimebutine maleate
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 20 mg octilonium bromide
Number of subjects: 60
Study: 30203841

Group type: EXPERIMENTAL
Intervention: Avatrombopag 20 mg daily for 14 days
Number of subjects: 92

Group type: COMPARATOR
Intervention: Avatrombopag (1, 3, 10, 20, 50, 75 and 100 mg)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Avatrombopag (3, 10 and 20 mg)
Number of subjects: 92
Study: 26321236

Group type: EXPERIMENTAL
Intervention: Dual-site biventricular pacing
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Single-site LV only pacing
Number of subjects: 126

Group type: COMPARATOR
Intervention: Non-implanted control
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Pooled pacing therapy
Number of subjects: 126
Study: 23889105

Group type: EXPERIMENTAL
Intervention: 2 g intravenous Cefazoline administered prior to skin incision
Number of subjects: 100

Group type: COMPARATOR
Intervention: 2 g intravenous Cefazoline administered immediately after cord clamping
Number of subjects: 100
Study: 22134627

Group type: EXPERIMENTAL
Intervention: Polysporin Triple ointment (P(3))
Number of subjects: 201

Group type: COMPARATOR
Intervention: mupirocin
Number of subjects: 201
Study: 20419592

Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia (n = 6)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (normoxia, n = 5)
Number of subjects: 11
Study: 18097177

Group type: COMPARATOR
Intervention: Orbital radiotherapy alone
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Orbital radiotherapy
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Orbital radiotherapy combined with oral corticosteroids
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Orbital radiotherapy combined with intravenous methylprednisolone
Number of subjects: 18
Study: 15966883

Group type: EXPERIMENTAL
Intervention: AmF/SnF(2) dentifrice-mouth rinse combination
Number of subjects: 281

Group type: COMPARATOR
Intervention: NaF-containing dentifrice
Number of subjects: 281
Study: 12693349

Group type: EXPERIMENTAL
Intervention: TENS (Transcutaneous Electrical Nerve Stimulation)
Number of subjects: 0
Study: 10471987

Group type: EXPERIMENTAL
Intervention: Cisapride (20 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cisapride with Pantoprazole (40 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cisapride alone and with Pantoprazole
Number of subjects: 0
Study: 9185249

Group type: EXPERIMENTAL
Intervention: HIV/AIDS educational pamphlet distributed to every household in 12 villages in spring 1992
Number of subjects: 954

Group type: EXPERIMENTAL
Intervention: HIV/AIDS educational pamphlet
Number of subjects: 954

Group type: COMPARATOR
Intervention: Secular trends and increased communication between villagers
Number of subjects: 954
Study: 8335505

Group type: EXPERIMENTAL
Intervention: IFN-alpha priming followed by IFN-alpha therapy (10 MU thrice-weekly for three months)
Number of subjects: 37

Group type: COMPARATOR
Intervention: IFN-alpha therapy (10 MU thrice-weekly for three months)
Number of subjects: 37
Study: 3743147

Group type: EXPERIMENTAL
Intervention: Instillation of 50 ml of 0.1 N hydrochloric acid in Group 3
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Atropine pretreatment (0.01 mg/kg twice daily) followed by instillation of acid in Group 3
Number of subjects: 39

Group type: COMPARATOR
Intervention: Instillation of 50 ml of isotonic sodium chloride solution
Number of subjects: 39
Study: 31243870

Group type: EXPERIMENTAL
Intervention: Nutrition intervention during radiotherapy
Number of subjects: 15
Study: 29596950

Group type: EXPERIMENTAL
Intervention: Group-based lifestyle intervention (GLI)
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Group-based lifestyle intervention (GLI) attendance
Number of subjects: 331

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 331
Study: 27567918

Group type: EXPERIMENTAL
Intervention: Methoxyflurane (up to 6 mL)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Methoxyflurane
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study: 24837215

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 340

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 340
Study: 22679908

Group type: EXPERIMENTAL
Intervention: Tianeptine (37.5 mg) with probiotics (Bacillus subtilis + Streptococcus faecium)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Amitriptyline (10 mg) with probiotics (Bacillus subtilis + Streptococcus faecium)
Number of subjects: 228
Study: 20081065

Group type: COMPARATOR
Intervention: Single ascending dose (SAD) of edoxaban (10, 30, 60, 90, 120, 150 mg)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Multiple ascending dose (MAD) of edoxaban (90 mg daily, 60 mg twice daily, 120 mg daily)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Edoxaban (both SAD and MAD)
Number of subjects: 121
Study: 18316122

Group type: EXPERIMENTAL
Intervention: Hostile priming condition
Number of subjects: 196

Group type: COMPARATOR
Intervention: Neutral priming condition
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Subliminal exposure to hostility-related words (Experiment 2)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Supraliminal exposure to hostility-related words (Experiment 1)
Number of subjects: 196
Study: 15951655

Group type: EXPERIMENTAL
Intervention: Tiagabine (maximum dose 24 mg/day)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Gabapentin (2400 mg/day)
Number of subjects: 91
Study: 12546606

Group type: EXPERIMENTAL
Intervention: Creatine kinase (CK) measurement
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Cardiac troponin I and T measurement
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: CK-MB measurement
Number of subjects: 152
Study: 10229489

Group type: EXPERIMENTAL
Intervention: 0.5% metoclopramide
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.25% droperidol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isotonic saline (placebo)
Number of subjects: 40
Study: 8934107

Group type: EXPERIMENTAL
Intervention: 2500 XaI units of low molecular weight heparin daily
Number of subjects: 2070

Group type: EXPERIMENTAL
Intervention: 5000 XaI units of low molecular weight heparin daily
Number of subjects: 2070
Study: 1930768

Group type: EXPERIMENTAL
Intervention: Methanol exposure at 250 mg/m3 for 75 minutes
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham exposure
Number of subjects: 12
Study: 6131124

Group type: EXPERIMENTAL
Intervention: Quitting smoking during the year following hospitalization
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Using psychotropic drugs (benzodiazepines)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: High psychosocial stress levels one year after discharge
Number of subjects: 157

Group type: COMPARATOR
Intervention: Stress
Number of subjects: 157

Group type: COMPARATOR
Intervention: Quitting smoking
Number of subjects: 157
Study: 31123862

Group type: EXPERIMENTAL
Intervention: 40 g bovine colostrum for 4.5 hours
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 20 g bovine colostrum per day for 4 weeks
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 20 g bovine colostrum per day for 12 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo for 4.5 hours
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 16
Study: 31271359

Group type: EXPERIMENTAL
Intervention: Reduced unit dose of rabies immunoglobulin (RIG) for class 3 rabid animal bites
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of research methodology (randomised controlled trial)
Number of subjects: 0
Study: 28789655

Group type: EXPERIMENTAL
Intervention: New elastic cuff
Number of subjects: 63

Group type: COMPARATOR
Intervention: Conventional cuff
Number of subjects: 63
Study: 26033066

Group type: EXPERIMENTAL
Intervention: Porous titanium granules
Number of subjects: 20

Group type: COMPARATOR
Intervention: Autograft bone
Number of subjects: 20
Study: 24291047

Group type: EXPERIMENTAL
Intervention: Straight humeral nail (MultiLoc, Synthes)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Curvilinear nail (Polarus, Acumed)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 54
Study: 23276084

Group type: EXPERIMENTAL
Intervention: Conventional Cawthorne&Cooksey protocol
Number of subjects: 68

Group type: COMPARATOR
Intervention: Multimodal Cawthorne&Cooksey protocol
Number of subjects: 68
Study: 19482890

Group type: EXPERIMENTAL
Intervention: Real taping
Number of subjects: 16

Group type: COMPARATOR
Intervention: No taping
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo taping
Number of subjects: 16
Study: 17552299

Group type: EXPERIMENTAL
Intervention: Atraumatic Restorative Treatment (ART)
Number of subjects: 403

Group type: COMPARATOR
Intervention: Conventional restorative treatment using rotary instruments (750 rpm)
Number of subjects: 403
Study: 15117306

Group type: EXPERIMENTAL
Intervention: Pyrimethamine-sulphadoxine plus probenecid (20-25 mg/kg in two divided doses daily for 3 days)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Pyrimethamine-sulphadoxine (25 mg/kg of the sulphadoxine component)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Pyrimethamine-sulphadoxine plus probenecid
Number of subjects: 151

Group type: COMPARATOR
Intervention: Pyrimethamine-sulphadoxine
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Both treatment regimens
Number of subjects: 151
Study: 11453853

Group type: EXPERIMENTAL
Intervention: PPV with perfluorodecalin (study, n=12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: PPV without perfluorodecalin (control, n=12)
Number of subjects: 24
Study: 9704688

Group type: EXPERIMENTAL
Intervention: On-vasodilator group
Number of subjects: 32

Group type: COMPARATOR
Intervention: Off-vasodilator group
Number of subjects: 32
Study: 7803248

Group type: EXPERIMENTAL
Intervention: IVIg 500 mg/kg every 4 weeks for 1 year
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: IVIg 250 mg/kg every 4 weeks for 1 year
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (from previous study)
Number of subjects: 34
Study: 3053668

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 43
Study: 31553946

Group type: EXPERIMENTAL
Intervention: 5A's model for PA counseling with weekly motivational text messages
Number of subjects: 59

Group type: COMPARATOR
Intervention: Fitbit only (Control)
Number of subjects: 59
Study: 28007790

Group type: EXPERIMENTAL
Intervention: Expressive Writing Intervention (EWI)
Number of subjects: 295

Group type: COMPARATOR
Intervention: Neutral Writing Control
Number of subjects: 295
Study: 26215384

Group type: EXPERIMENTAL
Intervention: Cycled lighting system in ICU room
Number of subjects: 119

Group type: COMPARATOR
Intervention: Ordinary lighting environment in ICU room
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Cycled lighting environment
Number of subjects: 119
Study: 24074607

Group type: EXPERIMENTAL
Intervention: Garlic products (minced and granule forms)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chinese freeze-dried garlic
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Allyl disulphide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Levamisole (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Garlic products (general)
Number of subjects: 0
Study: 21950394

Group type: EXPERIMENTAL
Intervention: Infant massage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care only (comparison group)
Number of subjects: 0
Study: 18997911

Group type: EXPERIMENTAL
Intervention: Adper Prompt L‐Pop
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: VivaSens
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Copalite
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unlined restorations
Number of subjects: 20
Study: 17159028

Group type: EXPERIMENTAL
Intervention: Surgical treatment for glaucoma (cataract extraction)
Number of subjects: 607

Group type: COMPARATOR
Intervention: Medical treatment for glaucoma
Number of subjects: 607
Study: 12897178

Group type: EXPERIMENTAL
Intervention: L-NAME (4 mg kg-1 in 50 ml saline over 60 min)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (without L-NAME)
Number of subjects: 7
Study: 10636614

Group type: EXPERIMENTAL
Intervention: 30 degree Trendelenburg position with head straight
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 30 degree Trendelenburg position with head rotated to the right
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 30 degree Trendelenburg position with head rotated to the left
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Head flexed and rotated to the right
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Head flexed and rotated to the left
Number of subjects: 15
Study: 8874841

Group type: EXPERIMENTAL
Intervention: Tryptophan-free amino acid mixture
Number of subjects: 12

Group type: COMPARATOR
Intervention: All essential amino acids mixture (control)
Number of subjects: 12
Study: 1528102

Group type: EXPERIMENTAL
Intervention: Intravenous PCA (IPCA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Epidural PCA (EPCA)
Number of subjects: 20
Study: 3698693

Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg orally)
Number of subjects: 9
Study: 30975627

Group type: EXPERIMENTAL
Intervention: Erlotinib plus bevacizumab (150 mg per day erlotinib + 15 mg/kg bevacizumab once every 21 days)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Erlotinib alone (150 mg per day)
Number of subjects: 228
Study: 29905969

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation, adjusted to maintain serum 25(OH)D above 75 nmol/L
Number of subjects: 260

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 260
Study: 26725183

Group type: EXPERIMENTAL
Intervention: Pemetrexed plus Cisplatin followed by Gefitinib (PC/G)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Gefitinib monotherapy (G)
Number of subjects: 236
Study: 25168762

Group type: EXPERIMENTAL
Intervention: 12-week sports-oriented exercise programme
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Web-delivered self-help tool to promote and support sports participation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of sports-oriented exercise programme and web-delivered self-help tool
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care general practitioner referral for gym-based exercise (Control)
Number of subjects: 0
Study: 22442436

Group type: EXPERIMENTAL
Intervention: Pulsed dexamethasone (6 monthly pulses)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Daily prednisolone (8 months)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Pulsed dexamethasone
Number of subjects: 39

Group type: COMPARATOR
Intervention: Daily prednisolone
Number of subjects: 39

Group type: COMPARATOR
Intervention: None (treatment-nonresponsive patients)
Number of subjects: 39
Study: 20089781

Group type: EXPERIMENTAL
Intervention: Active malaria morbidity management (trial group)
Number of subjects: 929

Group type: COMPARATOR
Intervention: Control group (no active malaria morbidity management)
Number of subjects: 929
Study: 17700050

Group type: EXPERIMENTAL
Intervention: Brief Dynamic Therapy (BDT) combined with antidepressants
Number of subjects: 35

Group type: COMPARATOR
Intervention: Supportive Psychotherapy (BSP) combined with antidepressants
Number of subjects: 35
Study: 15969353

Group type: EXPERIMENTAL
Intervention: Methylphenidate (Mph)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 12874937

Group type: EXPERIMENTAL
Intervention: NIC reminiscence intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Customary reminiscence intervention
Number of subjects: 30
Study: 11820944

Group type: EXPERIMENTAL
Intervention: Albuterol
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Ipratropium
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Albuterol + Ipratropium
Number of subjects: 91
Study: 8674228

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (200 micrograms applied to one nostril daily for 3 weeks)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (200 micrograms applied to one nostril daily for 3 weeks)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Matched placebo (applied to the other nostril)
Number of subjects: 12
Study: 2061366

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 6367013

Group type: EXPERIMENTAL
Intervention: Selective gastric vagotomy (SGV)
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Parietal cell vagotomy (PCV)
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Selective gastric vagotomy (SGV) and Parietal cell vagotomy (PCV)
Number of subjects: 685
Study: 30849343

Group type: EXPERIMENTAL
Intervention: Telemetric IOP measurement using Eyemate-IO sensor
Number of subjects: 12

Group type: COMPARATOR
Intervention: Finger palpation for IOP assessment
Number of subjects: 12
Study: 29580348

Group type: EXPERIMENTAL
Intervention: Prosthetic mesh repair
Number of subjects: 208

Group type: COMPARATOR
Intervention: Primary suture repair
Number of subjects: 208
Study: 26419675

Group type: EXPERIMENTAL
Intervention: Full-mouth subgingival ultrasonic instrumentation followed by Er:YAG laser application 1 week later to sites with initial probing pocket depth ≥4.5 mm
Number of subjects: 40

Group type: COMPARATOR
Intervention: Full-mouth ultrasonic subgingival instrumentation within 1 week
Number of subjects: 40
Study: 25082715

Group type: EXPERIMENTAL
Intervention: Zolpidem (10mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 21762561

Group type: EXPERIMENTAL
Intervention: Noninvasive PEEP at 5 cm H(2)O
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Noninvasive PEEP at 10 cm H(2)O
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Noninvasive PEEP at 15 cm H(2)O
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pressure-support ventilation (PSV) at 5 cm H(2)O
Number of subjects: 30
Study: 21077346

Group type: EXPERIMENTAL
Intervention: Nifedipine CR (NCR) dose uptitration (VAL 80 mg + NCR 40 mg)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Valsartan (VAL) dose uptitration (VAL 160 mg + NCR 20 mg)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Nifedipine CR (NCR) dose uptitration
Number of subjects: 31

Group type: COMPARATOR
Intervention: Valsartan (VAL) dose uptitration
Number of subjects: 31
Study: 17568867

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg/day for three days, n = 49)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Amoxicillin (500 mg every eight hours for ten days, n = 53)
Number of subjects: 109
Study: 15697042

Group type: EXPERIMENTAL
Intervention: High-frequency 10 Hz rTMS over 10 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 20
Study: 12389708

Group type: EXPERIMENTAL
Intervention: Nucleic Acid Sequence‐Based Amplification (NASBA) assay on blood cultures after 2 days of culturing
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nucleic Acid Sequence‐Based Amplification (NASBA) assay on whole blood samples
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nucleic Acid Sequence‐Based Amplification (NASBA) assay
Number of subjects: 10

Group type: COMPARATOR
Intervention: Automated blood culturing
Number of subjects: 10
Study: 9813870

Group type: EXPERIMENTAL
Intervention: Oral Mg supplementation (500 mg Mg-oxide.d-1 for 3 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 7710435

Group type: EXPERIMENTAL
Intervention: Treatment A (20 mg isosorbide-5-mononitrate, oral)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Treatment B (20 mg isosorbide-5-mononitrate, oral)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Treatment C (20 mg isosorbide-5-mononitrate, intravenous)
Number of subjects: 24
Study: 2654019

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole
Number of subjects: 44

Group type: COMPARATOR
Intervention: Norfloxacin
Number of subjects: 44
Study: 380578

Group type: EXPERIMENTAL
Intervention: Viloxazine (n = 9)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Amitriptyline (n = 10)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 19
Study: 30473139

Group type: EXPERIMENTAL
Intervention: Spironolactone 12.5 mg daily
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg daily
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Spironolactone 50 mg daily
Number of subjects: 129
Study: 27646835

Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan 97/103 mg two times daily
Number of subjects: 414

Group type: COMPARATOR
Intervention: irbesartan 300 mg one time daily
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 414
Study: 25962118

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) intervention (Uphungu Wanga)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Brief education alone
Number of subjects: 28
Study: 23642942

Group type: EXPERIMENTAL
Intervention: Panax notoginseng 4000 mg capsules
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 21942957

Group type: EXPERIMENTAL
Intervention: If channel inhibitor ivabradine (12.1±2.3 mg/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Slow release metoprolol succinate (59.1±4.5 mg/day)
Number of subjects: 100
Study: 19420144

Group type: EXPERIMENTAL
Intervention: Recent falls
Number of subjects: 1709

Group type: EXPERIMENTAL
Intervention: Fear of falling
Number of subjects: 1709

Group type: EXPERIMENTAL
Intervention: Fall prevention behaviours
Number of subjects: 1709
Study: 16691378

Group type: EXPERIMENTAL
Intervention: DWI with b = 0, 150, 500 s/mm2 images
Number of subjects: 40
Study: 15364868

Group type: EXPERIMENTAL
Intervention: Selective antegrade cerebral perfusion (SACP)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Hypothermic circulatory arrest (HCA)
Number of subjects: 42
Study: 11312477

Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 65
Study: 9395351

Group type: EXPERIMENTAL
Intervention: cpts530/1009
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: cpts248/955
Number of subjects: 0

Group type: COMPARATOR
Intervention: cpts530/1009 and cpts248/955
Number of subjects: 0